Skip to main content
OpenTrials
Completed

NCT Number: NCT01019018

Efficacy of Subtenon's Block With Olive Tipped Cannula

The purpose of this study is to compare the efficacy of olive tip cannula to the standard Steven's cannula in performing subtenon's anesthesia for patients undergoing cataract surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

king Khaled Eye Specialist hospital

Riyadh, 11462, Saudi Arabia

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient undergoing cataract extraction procedure under local anesthesia

Exclusion criteria

  • Patients allergic to local anesthetic solutions.
  • Presence local sepsis,
  • Previous retinal or strabismus surgery in the same eye.
  • Orbital abnormalities
  • Previous subtenon's block in the same quadrant.

Treatment and study plan

subtenon block

Device

subtenon block with stevens cannula

Primary outcomes

  1. Measurement of Akinesia score

    Time frame: 10 minutes after the block

Secondary outcomes

  1. Surgeon satisfactions score

    Time frame: At the end of the procedure

Sponsors and collaborators

Lead sponsor

King Khaled Eye Specialist Hospital

Other Gov

Registry information

Official study title

Efficacy of Subtenon Anesthesia With Olive Tipped Cannula: a Randomized Controlled Trial

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Nov 25, 2009
Registry last updated
Oct 21, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.